Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2021-08-02 00:00:00 ET · period of report 2021-07-29 · accession 0000899243-21-031086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-02 | 2021-07-29 | CADL | Caffo Nathan | Chief Business Off | P - Purchase | $8.00 | +6,000 | 6,000 | New | +$48.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-29 | P | A | 6,000 | $8.00 | 6,000 | D | — | — |